Form D · Other Health Care
ProZyme, Inc.
Hayward, CA · CIK 0001532581
Offering snapshot reported Oct 14, 2011 · SEC filing
- Reported sold
- $321K Offering amount: $998K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Sep 8, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 14, 2011 | Initial | $321,414 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-167337
Source: Form D, filed Oct 14, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aubrey Bruce Amsden | Director, Executive |
| David Belgum | Executive |
| Pamela Esmon | Director |
| Francis A Farina | Director |
| Susan C Fuller | Director |
| E J Wegstein | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3832 Bay Center Place
Hayward, CA, 94545
Hayward, CA, 94545